Pterostilbene protects vascular endothelial cells against oxidized low-density lipoprotein-induced apoptosis in vitro and in vivo

Apoptosis

Volumn 17, Issue 1, 2012, Pages 25-36

  Zhang, Lu ^a   Zhou, Guang Zhou ^a   Song, Wei ^a   Tan, Xiao Rong ^a   Guo, Yu Qi ^b   Zhou, Bo ^c   Jing, Hongjuan ^a   Zhao, Su Juan ^a   Chen, Liang Ke ^a  

^a HENAN UNIVERSITY OF TECHNOLOGY   (China)

^b ZHENGZHOU UNIVERSITY   (China)

^c LANZHOU UNIVERSITY   (China)

Author keywords

Apoptosis; Atherosclerosis; Lectin like oxLDL receptor 1; Oxidized low density lipoprotein; Pterostilbene; Vascular endothelial cell

Indexed keywords

CASPASE 3; CASPASE 9; CYTOCHROME C; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; OXIDIZED LOW DENSITY LIPOPROTEIN; OXIDIZED LOW DENSITY LIPOPROTEIN RECEPTOR 1; PROTEIN P53; PTEROSTILBENE; REACTIVE OXYGEN METABOLITE; SMALL INTERFERING RNA; STILBENE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; CELL CULTURE; CELL VIABILITY; CONTROLLED STUDY; DRUG DOSE COMPARISON; DRUG MEGADOSE; ENDOTHELIUM CELL; ENZYME ACTIVITY; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LOW DRUG DOSE; MALE; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RNA INTERFERENCE; VASCULAR ENDOTHELIUM; WESTERN BLOTTING;

ANIMALS; APOPTOSIS; ATHEROSCLEROSIS; ENDOTHELIAL CELLS; HUMANS; LIPOPROTEINS, LDL; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PROTECTIVE AGENTS; STILBENES;

MUS;

EID: 84856745984     PISSN: 13608185     EISSN: 1573675X     Source Type: Journal    
DOI: 10.1007/s10495-011-0653-6     Document Type: Article

References (46)

1. Libby P (2002) Inflammation in atherosclerosis. Nature 420: 868-874 (Pubitemid 36019640)
2. Rajagopalan S, Somers EC, Brook RD, Kehrer C, Pfenninger D, Lewis E, Chakrabarti A, Richardson BC, Shelden E, McCune WJ, Kaplan MJ (2004) Endothelial cell apoptosis in systemic lupus erythematosus: a common pathway for abnormal vascular function and thrombosis propensity. Blood 103:3677-3683 (Pubitemid 38596281)
3. Durand E, Scoazec A, Lafont A, Boddaert J, Al Hajzen A, Addad F, Mirshahi M, Desnos M, Tedgui A, Mallat Z (2004) In vivo induction of endothelial apoptosis leads to vessel thrombosis and endothelial denudation: a clue to the understanding of the mechanisms of thrombotic plaque erosion. Circulation 109:2503-2506 (Pubitemid 38720547)
4. Liu S, Shen H, Xu M, Liu O, Zhao L, Liu S, Guo Z, Du J (2010) FRP inhibits ox-LDL-induced endothelial cell apoptosis through an Akt-NF-(kappa)B-Bcl-2 pathway and inhibits endothelial cell apoptosis in an apoE-knockout mouse model. Am J Physiol Endocrinol Metab 299:E351-E363
5. Ross R (1993) The pathogenesis of atherosclerosis: a perspective for the 1990 s. Nature 362:801-809
6. Chen J, Mehta JL, Haider N, Zhang X, Narula J, Li D (2004) Role of caspases in Ox-LDL-induced apoptotic cascade in human coronary artery endothelial cells. Circ Res 94:370-376 (Pubitemid 38240729)
7. Kume N, Kita T (2001) Lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1) in atherogenesis. Trends Cardiovasc Med 11:22-25 (Pubitemid 32544950)
8. Chen XP, Xun KL, Wu Q, Zhang TT, Shi JS, Du GH (2007) Oxidized low density lipoprotein receptor-1 mediates oxidized low density lipoprotein-induced apoptosis in human umbilical vein endothelial cells: role of reactive oxygen species. Vascul Pharmacol 47:1-9 (Pubitemid 46830770)
9. Li D, Mehta JL (2009) Intracellular signaling of LOX-1 in endothelial cell apoptosis. Circ Res 104:566-568
10. Mannal PW, Alosi JA, Schneider JG, McDonald DE, McFadden DW (2010) Pterostilbene inhibits pancreatic cancer in vitro. J Gastrointest Surg 14:873-879
11. Remsberg CM, Yáñez JA, Roupe KA, Davies NM (2007) Highperformance liquid chromatographic analysis of pterostilbene in biological fluids using fluorescence detection. J Pharm Biomed Anal 43:250-254 (Pubitemid 44873180)
12. Chen RJ, Ho CT, Wang YJ (2010) Pterostilbene induces autophagy and apoptosis in sensitive and chemoresistant human bladder cancer cells. Mol Nutr Food Res 54:1819-1832
13. Remsberg CM, Yáñez JA, Ohgami Y, Vega-Villa KR, Rimando AM, Davies NM (2008) Pharmacometrics of pterostilbene: preclinical pharmacokinetics and metabolism, anticancer, antiinflammatory, antioxidant and analgesic activity. Phytother Res 22:169-179 (Pubitemid 351363234)
14. Pari L, Satheesh MA (2006) Effect of pterostilbene on hepatic key enzymes of glucose metabolism in streptozotocin- and nicotinamide- induced diabetic rats. Life Sci 79:641-645 (Pubitemid 43927983)
15. Park ES, Lim Y, Hong JT, Yoo HS, Lee CK, Pyo MY, Yun YP (2010) Pterostilbene, a natural dimethylated analog of resveratrol, inhibits rat aortic vascular smooth muscle cell proliferation by blockingAkt-dependent pathway.Vascul Pharmacol 53(1-2):61-67
16. Cichocki M, Paluszczak J, Szaefer H, Piechowiak A, Rimando AM, Baer-Dubowska W (2008) Pterostilbene is equally potent as resveratrol in inhibiting 12-O-tetradecanoylphorbol-13-acetate activated NFkappaB, AP-1, COX-2, and iNOS in mouse epidermis. Mol Nutr Food Res 52(Suppl 1):S62-S70
17. Chang HC, Chen TG, Tai YT, Chen TL, Chiu WT, Chen RM (2011) Resveratrol attenuates oxidized LDL-evoked Lox-1 signaling and consequently protects against apoptotic insults to cerebrovascular endothelial cells. J Cereb Blood Flow Metab 31:842-854
18. Lin YL, Chang HC, Chen TL, Chang JH, Chiu WT, Lin JW, Chen RM (2010) Resveratrol protects against oxidized LDL-induced breakage of the blood-brain barrier by lessening disruption of tight junctions and apoptotic insults to mouse cerebrovascular endothelial cells. J Nutr 140:2187-2192
19. Asensi M, Medina I, Ortega A, Carretero J, Baño MC, Obrador E, Estrela JM (2002) Inhibition of cancer growth by resveratrol is related to its low bioavailability. Free Radic Biol Med 33: 387-398 (Pubitemid 34786278)
20. Lin HS, Yue BD, Ho PC (2009) Determination of pterostilbene in rat plasma by a simple HPLC-UV method and its application in pre-clinical pharmacokinetic study. Biomed Chromatogr 23: 1308-1315
21. Jaffe EA, Nachman RL, Becker CG, Minick CR (1973) Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. J Clin Invest 52:2745-2756
22. Hessler JR, Morel DW, Lewis LJ, Chisolm GM (1983) Lipoprotein oxidation and lipoprotein-induced cytotoxicity. Arteriosclerosis 3:215-222 (Pubitemid 13099583)
23. Price P, McMillan TJ (1990) Use of the tetrazolium assay in measuring the response of human tumor cells to ionizing radiation. Cancer Res 50:1392-1396 (Pubitemid 20090446)
24. Suematsu N, Tsutsui H, Wen J, Kang D, Ikeuchi M, Ide T, Hayashidani S, Shiomi T, Kubota T, Hamasaki N, Takeshita A (2003) Oxidative stress mediates tumor necrosis factor-alphainduced mitochondrial DNA damage and dysfunction in cardiac myocytes. Circulation 107:1418-1423 (Pubitemid 36350742)
25. Bedner E, Li X, Gorczyca W, Melamed MR, Darzynkiewicz Z (1999) Analysis of apoptosis by laser scanning cytometry. Cytometry 35:181-195 (Pubitemid 29104396)
26. Liu X, Sun J (2010) Endothelial cells dysfunction induced by silica nanoparticles through oxidative stress via JNK/P53 and NFkappaB pathways. Biomaterials 31:8198-8209
27. Aoki M, Nata T, Morishita R, Matsushita H, Nakagami H, Yamamoto K, Yamazaki K, Nakabayashi M, Ogihara T, Kaneda Y (2001) Endothelial apoptosis induced by oxidative stress through activation of NF-kappaB: antiapoptotic effect of antioxidant agents on endothelial cells. Hypertension 38:48-55 (Pubitemid 34224770)
28. Ou HC, Lee WJ, Lee SD, Huang CY, Chiu TH, Tsai KL, Hsu WC, Sheu WH (2010) Ellagic acid protects endothelial cells from oxidized low-density lipoprotein-induced apoptosis by modulating the PI3 K/Akt/eNOS pathway. Toxicol Appl Pharmacol 248:134-143
29. Marsden VS, O'Connor L, O'Reilly LA, Silke J, Metcalf D, Ekert PG, Huang DC, Cecconi F, Kuida K, Tomaselli KJ, Roy S, Nicholson DW, Vaux DL, Bouillet P, Adams JM, Strasser A(2002) Apoptosis initiated by Bcl-2-regulated caspase activation independently of the cytochrome C/Apaf-1/caspase-9 apoptosome. Nature 419:634-637
30. Zhang L, Zhao J, Su L, Huang B, Wang L, Su H, Zhang Y, Zhang S, Miao J (2010) D609 inhibits progression of preexisting atheroma and promotes lesion stability in apolipoprotein e-/- mice: a role of phosphatidylcholine-specific phospholipase in atherosclerosis. Arterioscler Thromb Vasc Biol 30:411-418
31. Kushi LH, Meyer KA, Jacobs DR Jr (1999) Cereals, legumes, and chronic disease risk reduction: evidence from epidemiologic studies. Am J Clin Nutr 70:451S-458S (Pubitemid 29407123)
32. Dauchet L, Amouyel P, Dallongeville J, Medscape (2009) Fruits, vegetables and coronary heart disease. Nat Rev Cardiol 6: 599-608
33. Petrovski G, Gurusamy N, Das DK (2011) Resveratrol in cardiovascular health and disease. Ann N Y Acad Sci 1215:22-33
34. de la Lastra CA, Villegas I (2005) Resveratrol as an anti-inflammatory and anti-aging agent: mechanisms and clinical implications. Mol Nutr Food Res 49:405-430 (Pubitemid 40780389)
35. Salvayre R, Auge N, Benoist H, Negre-Salvayre A (2002) Oxidized low-density lipoprotein-induced apoptosis. Biochim Biophys Acta 1585:213-221 (Pubitemid 36092085)
36. Pendurthi UR, Williams JT, Rao LV (1999) Resveratrol, a polyphenolic compound found in wine, inhibits tissue factor expression in vascular cells: A possible mechanism for the cardiovascular benefits associated with moderate consumption of wine. Arterioscler Thromb Vasc Biol 19:419-426 (Pubitemid 29072759)
37. Chiou YS, Tsai ML, Nagabhushanam K, Wang YJ, Wu CH, Ho CT, Pan MH (2011) Pterostilbene Is More Potent than Resveratrol in Preventing Azoxymethane (AOM)-Induced Colon Tumorigenesis via Activation of the NF-E2-Related Factor 2 (Nrf2)-Mediated Antioxidant Signaling Pathway. J Agric Food Chem 59:2725-2733
38. Ou HC, Chou FP, Sheen HM, Lin TM, Yang CH, Huey-Herng Sheu W (2006) Resveratrol, a polyphenolic compound in red wine, protects against oxidized LDL-induced cytotoxicity in endothelial cells. Clin Chim Acta 364:196-204 (Pubitemid 43120641)
39. Yang Z, von Ballmoos MW, Faessler D, Voelzmann J, Ortmann J, Diehm N, Kalka-Moll W, Baumgartner I, Di Santo S, Kalka C (2010) Paracrine factors secreted by endothelial progenitor cells prevent oxidative stress-induced apoptosis of mature endothelial cells. Atherosclerosis 211:103-109
40. Irani K (2000) Oxidant signaling in vascular cell growth, death, and survival: a review of the roles of reactive oxygen species in smooth muscle and endothelial cell mitogenic and apoptotic signaling. Circ Res 87:179-183 (Pubitemid 30626423)
41. Lee WJ, Ou HC, Hsu WC, Chou MM, Tseng JJ, Hsu SL, Tsai KL, Sheu WH (2010) Ellagic acid inhibits oxidized LDL-mediated LOX-1 expression, ROS generation, and inflammation in human endothelial cells. J Vasc Surg 52:1290-1300
42. Ou HC, Chou FP, Sheu WH, Hsu SL, Lee WJ (2007) Protective effects of magnolol against oxidized LDL-induced apoptosis in endothelial cells. Arch Toxicol 81:421-432 (Pubitemid 46980505)
43. Lu J, Yang JH, Burns AR, Chen HH, Tang D, Walterscheid JP, Suzuki S, Yang CY, Sawamura T, Chen CH (2009) Mediation of electronegative low-density lipoprotein signaling by LOX-1: a possible mechanism of endothelial apoptosis. Circ Res 104: 619-627
44. Mattaliano MD, Huard C, Cao W, Hill AA, Zhong W, Martinez RV, Harnish DC, Paulsen JE, Shih HH (2009) LOX-1-dependent transcriptional regulation in response to oxidized LDL treatment of human aortic endothelial cells. Am J Physiol Cell Physiol 296:C1329-C1337
45. Cominacini L, Pasini AF, Garbin U, Davoli A, Tosetti ML, Campagnola M, Rigoni A, Pastorino AM, Lo Cascio V, Sawamura T (2000) Oxidized low density lipoprotein (ox-LDL) binding to ox-LDL receptor-1 in endothelial cells induces the activation of NF-kappaB through an increased production of intracellular reactive oxygen species. J Biol Chem 275:12633-12638 (Pubitemid 30241412)
46. Ruiz MJ, Fernández M, Picó Y, Mañes J, Asensi M, Carda C, Asensio G, Estrela JM (2009) Dietary administration of high doses of pterostilbene and quercetin to mice is not toxic. J Agric Food Chem 57:3180-3186